biontech se biːˈɒntɛk beeontek baɪˈɒntɛk short biopharmaceutical new technologies german biotechnology company based mainz develops manufactures active immunotherapies patientspecific approaches treatment diseases develops pharmaceutical candidates based messenger ribonucleic acid mrna use individualized cancer immunotherapies vaccines infectious diseases protein replacement therapies rare diseases also engineered cell therapy novel antibodies small molecule immunomodulators treatment options cancer company developed mrnabased human therapeutic intravenous administration bring individualized mrnabased cancer immunotherapy clinical trials establish manufacturing biontech partnering pfizer testing logistics developed rna vaccine preventing infections time offered preventing confirmed occurring least days second dose december temporary hmr authorization granted united kingdom government vaccinations within united first mrna vaccine ever authorized days later vaccine also received emergency approval united december european commission approved biontechpfizers coronavirus vaccine accordance positive recommendation european medicines agency biontech founded based research uğur şahin özlem christoph seed investment million mig capital companys activities focus development production technologies drugs individualized cancer andreas thomas strüngmann michael motschmann helmut jeggle acquisition eufets jpt peptide technologies took hungarian biochemist katalin karikó whose work mrna whilst working university pennsylvania underpinned development winner nobel prize physiology joined biontech senior vice president many research results mrna mechanisms published collaborations commercialization programs concluded various companies scientific institutions starting period biontech filed several patent applications developed multilayered strategy protect intellectual property various technology platforms application treatment cancer serious diseasescitation needed august company entered multiyear research development rd collaboration us company pfizer inc develop mrnabased vaccines prevention influenza terms agreement following biontechs completion firstinhuman clinical study pfizer would assume sole responsibility clinical development commercialization mrnabased flu january sanofi invested million biontech extended mrna cancer research collaboration two companies sanofi previously paid million upfront rights five discoverystage immunotherapies biontech july fidelity management research company led series b investment round totalling million additional investments redmile group invus mirae asset financial group platinum asset management jebsen capital steam athena capital bioveda china fund struengmann family september biontech received capital contribution million bill melinda gates foundation option doubling investment amount later since october biontech newly founded north american headquarters cambridge massachusetts publicly traded american depository shares ads nasdaq global select market ticker symbol biontech able generate total gross proceeds million dollars biontech announced would open asia headquarters singapore also open vaccine manufacturing plant support singapore economic development singapore factory expected operational produce hundreds millions doses mrna vaccines per collaboration fosun pharma planned add facility china produce billion doses per year china macau hong kong taiwan though august prc approved foreigndeveloped july biontech acquired british startup instadeep million million order expand activities area artificial intelligence drug discovery design biontechs founding place global headquarters mainz germany vaccine created company runs multiple sites country research locations san diego cambridge massachusetts latter also serves north american headquarters additionally company owns gmpcertified production facilities idaroberstein martinsried neuried bavaria berlin november company acquired facilities novartis marburg ramp vaccine december biontech received million loan finance development patientspecific immunotherapies treatment cancer serious diseases european investment bank eib part european commission investment plan eib signed million loan june accelerated approval two months process usually takes year financing helped biontechs vaccine trials manufacturing eib loan part innovfin corporate research equity programme european fund strategic investments programme supports innovative higherrisk projects backed european investment bank guarantee european union march biontech received million investment fosun pharma exchange million shares biontech future development marketing rights mrna vaccine june biontech received million temasek holdings singapore via purchase ordinary shares years convertible notes also investors private placement mandatory convertible september german federal ministry education research bmbf awarded million grant biontech accelerate development project lightspeed project develop novel mrna technology vaccine began midjanuary days genetic sequence first made company partnered project production vaccine followed clinical trials success prerequisite commencement marketing november biontech pfizer announced people countries received test vaccine percent effectiveness basis successful testing asked right distribute vaccines united states well european union united kingdom july biontech pharmaceutical corporation pfizer signed contracts supply million doses japan million doses united states million doses united kingdom proven effective safe august canada preordered million doses september germany privately ordered million doses outside collective eu purchasing november australia preordered million november biontechpfizer released positive interim analysis phase iii clinical trial united states november biontech pfizer applied emergency use authorization eua fda reviewed fda released document explaining eua mechanism facilitate availability use medical countermeasures including vaccines public health emergencies current november european union preordered million doses initial price per dose agreement vaccineproducing pair biontech pfizer subject tightened legal obligation bring experience gained ema belgiums budget state secretary eva de bleeker accidentally revealed vaccine purchase priceperdose agreed eu various companies oxfordastrazeneca johnson johnson sanofigsk curevac moderna month israel ordered million doses month biontechpfizer submitted eua application december united kingdom granted conditional temporary authorization regulation human medicines regulations becoming first country approve mrna vaccine first western country approve vaccine national month revealed also evaluation eua status several december fosun pharma agreed deal deliver million doses biontechpfizer vaccine hong kong securing million doses december european medicines agency ema authorised oneyear conditional use biontechpfizer vaccine european union emer cooke director ema stated benefits vaccine far outweigh potential december following authorisation initial mass vaccination coronavirus commenced hungary january european union ordered additional million doses vaccine option million june us food drug administration fda added warning risk rare heart inflammation myocarditis specifications pfizerbiontech moderna vaccines date already million us citizens vaccinated twice one mrnabased vaccines according us centers disease control prevention early biontech started series clinical trials united kingdom mrna based immunotherapies targeting several types november interview german broadcaster zdf biontech ceo uğur şahin said company expects mrnabased therapeutic cancer vaccine approval biontech together pfizer cosponsored academy awards ceremony march main sponsorship pharmaceutical duo stated widespread use vaccines booster shots helped prevent diseases protect lives film industry partnered promote vaccines mask use prevention strategies biontechs spectacular marketing promotional success oscars sponsorship ability appear ahead huge pharma partner pfizer promotional duos ubiquitous roster significant achievement time biontech removed name vaccine almost every language world joint product mostly referred simply httpsenwikipediaorgwikibiontech